Skip to content

Clene Inc.

CLNN· NasdaqCore metricsCIK 1822791

Pharmaceutical preparations551 peers

Last sale
Nov 12, 2026 · -1.07%
Market cap
$59.83M
14.4M shares
Filings
715
$56.00K
Q3 2026−41.5% FY25 yoy
$3.92M
Q3 2026N/M FY25 yoy
-$6.35M
Q3 2026N/M FY25 yoy
-$11.79M
Q3 2026derivedN/M FY25 yoy
$0.05
Q3 2026N/M FY21 yoy
$9.89M
Q3 2026−57.3% FY25 yoy
$59.83M
—
251.4×
—
—
—

Twelve months to Sep 30, 2026 · derived

Price

$4.1657.30%$5.58past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$200.00KFY 2025
$723.00K0FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$200,000reported
FY 20242024-12-31$342,000reported
FY 20232023-12-31$654,000reported
FY 20222022-12-31$473,000reported
FY 20212021-12-31$723,000reported
FY 20202020-12-31$206,000reported

Segments

Revenue by Segments, FY2021 to FY2022FY2021Supplements Segment · FY2021 · $723.00KFY2022Supplements Segment · FY2022 · $473.00K
LineFY2022ShareChange
Supplements Segment$473.00K100%−34.6%
Drugs Segment$0.00——
Total$473.00K

From the 10-K filed Mar 13, 2023CLNN

Pharmaceutical preparations

Clene Inc. is the 238th largest of the 552 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Clene Inc. · CIK 1822791 · Engraved from SEC EDGAR